Search

Your search keyword '"Rosendahl, AH"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Rosendahl, AH" Remove constraint Author: "Rosendahl, AH" Search Limiters Full Text Remove constraint Search Limiters: Full Text
43 results on '"Rosendahl, AH"'

Search Results

1. A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort

5. Low-dose tamoxifen treatment reduces collagen organisation indicative of tissue stiffness in the normal breast: results from the KARISMA randomised controlled trial.

6. WHO-recommended levels of physical activity in relation to mammographic breast density, mammographic tumor appearance, and mode of detection of breast cancer.

7. TANGO1 inhibitors reduce collagen secretion and limit tissue scarring.

8. Degree of food processing and breast cancer risk: a prospective study in 9 European countries.

9. FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics.

10. Obesity and breast cancer prognosis: pre-diagnostic anthropometric measures in relation to patient, tumor, and treatment characteristics.

11. Zinc and Breast Cancer Survival: A Prospective Cohort Study of Dietary Intake and Serum Levels.

12. Physical Activity and Long-Term Risk of Breast Cancer, Associations with Time in Life and Body Composition in the Prospective Malmö Diet and Cancer Study.

13. Deletion of hypoxia-inducible factor prolyl 4-hydroxylase 2 in FoxD1-lineage mesenchymal cells leads to congenital truncal alopecia.

14. Pathophysiology of systemic sclerosis (scleroderma).

15. Genetic Variation Interacts with Selenium Exposure Regarding Breast Cancer Risk: Assessing Dietary Intake, Serum Levels and Genetically Elevated Selenium Levels.

16. Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies.

17. Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

18. Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality.

19. Local Biomarkers Involved in the Interplay between Obesity and Breast Cancer.

20. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.

21. Dietary intake of trans fatty acids and breast cancer risk in 9 European countries.

22. Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study.

23. Adipocytes Under Obese-Like Conditions Change Cell Cycle Distribution and Phosphorylation Profiles of Breast Cancer Cells: The Adipokine Receptor CAP1 Matters.

24. The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial.

25. Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer.

26. BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study.

27. Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis.

28. Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study.

29. Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment.

30. Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways.

31. Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer.

32. Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups.

33. High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.

34. Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: a comparative study.

35. Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer.

36. Muscle composition is regulated by a Lox-TGFβ feedback loop.

37. Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer.

38. Early activation of pulmonary TGF-β1/Smad2 signaling in mice with acute pancreatitis-associated acute lung injury.

39. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.

40. Acute lung injury in acute pancreatitis--awaiting the big leap.

41. Proteome-based biomarkers in pancreatic cancer.

42. IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells.

43. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.

Catalog

Books, media, physical & digital resources